The PanCancer Immune Profiling Panel is designed for a comprehensive study (360° view) of the immune response, facilitating immuno-oncology research. Furthermore, it includes genes related to the tumor biology and the tumoral microenvironment.
This panel could help you with the development of immunotherapy, the identification of tumor-infiltrating lymphocytes (TILs) in the microenvironment, to analyse the CT antigen expression in humans, to assess mechanistic pathway activity…
It incorporates the 18-gene Tumor Inflammation Signature (TIS), which measures a peripherally suppressed, adaptive immune response and has been shown to correlate with response to checkpoint inhibitors.
It includes 770 genes (request list) involved in 13 cancer-associated canonical pathways: Wnt, HedgeHog, apoptosis, cell cycle, RAS, PI3K, STAT, MAPK, Notch, TGF- β, chromatin modification, transcriptional regulation, and DNA damage control. This panel covers adaptive and innate immune response genes.
For more information about the pathways and processes included in the panel, the TIS, or the possibility of measuring the relative abundance of 14 different immune cell types, please, consult the product file you can download below or visit the NanoString web:
The PanCancer Immune Profiling Panel could be combined with a Panel Plus, which will allow you to add up to 55 genes chosen by the client.
If you want to check that this panel is the most suitable for you, you can go to the NanoString Panel Pro panel selection tool:
|nCounter PanCancer Immune Profiling Panel||Gene Expression CodeSet profiling (770 genes); 730 immune and cancer-related human genes + 40 internal reference controls. Master Kit reagents sold separately.||12 Reactions||XT-CSO-HIP1-12|